Category: Kinetic Concepts Inc.Syndicate content

ConMed ripe for M&A | The week in medtech M&A

May 27, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: ConMed ripe for M&A spree; Baxter looks to growth post-Baxalta spinout; Sorin shareholders OK Cyberonics Merger

Analyst: ConMed ripe for M&A spree

May 19, 2015 by Fink Densford

Analyst: ConMed ripe for M&A spree

Feds charge ex-JP Morgan exec, father in medtech insider trading scheme

May 15, 2015 by Brad Perriello

Federal prosecutors charge a former JP Morgan executive and his father with insider trading based on information gleaned from a spate of medtech mergers.

Feds charge ex-JP Morgan exec, father in medtech insider trading scheme

Federal prosecutors in New York this week charged a father-and-son team with insider trading connected with a spate of mergers in the medical device arena.

Acelity closes 2014 on a high note

February 19, 2015 by Mark Hollmer

Texas-based wound care giant Acelity closes out the year by narrowing net losses and healthy gains in wound care sales

Acelity, the Texas-based wound care company created last fall from 3 sister med tech outfits, ended 2014 on an up note by narrowing net losses and increasing sales.

Revenues for the 3-month period ending December 31, 2014 were $482.7 million, up from $462.4 million in the 2013 fourth quarter, reflecting a 4.4% increase. Net losses came in at $29.5 million, a big improvement over more than $52.7 million in net losses over the same period last year.

Failure of Medtronic's Symplicity-3 trial doesn't mean the end of renal denervation for hypertension | Medtech Wall Street news for the week of September 1, 2014

September 4, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Renal denervation isn't dead, despite Medtronic trial's failure; Baxter says HQ will stay in Illinois, stays coy on Boston plans; Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

September 3, 2014 by Brad Perriello

The private equity owners of sister companies Kinetic Concepts Inc., Systagenix and LifeCell are combining them into a single entity called Acelity.

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

The private equity owners of a trio of wound care and regenerative medicine companies said today that they're merging Kinetic Concepts Inc., Systagenix and LifeCell into a single entity called Acelity.

KCI settles Wake Forest wound care patent spat for $280M

July 1, 2014 by Brad Perriello

Kinetic Concepts Inc. agrees to a $280-million settlement of its long-running patent infringement war with Wake Forest University over negative-pressure wound therapy technology.

KCI settles Wake Forest wound care patent spat for $280M

UPDATED July 1, 2014, with comment from KCI.

Kinetic Concepts Inc. said it agreed to pay $280 million to settle a patent infringement lawsuit with Wake Forest University, putting their long-running war over negative-pressure wound therapy to rest.